Category: Antimicrobial Stewardship

Collection:  Antibiotic Stewardship Guidelines and Algorithms Compendium

Compiled by IPRO HQIC

Urinary Tract Infection – Guidelines

Guidelines for Treatment of Urinary Tract Infections Michigan Hospital Medicine Safety (HMS) Consortium

Urinary Tract Infection and Asymptomatic Bacteriuria Guidance Nebraska Medicine

URINARY TRACT INFECTIONS IN ADULTS Michigan Medicine, University of Michigan

Clinical Practice Guidelines for the Antibiotic Treatment of Community-Acquired Urinary Tract Infections NIH

UTI References

International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update. Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases 

Topic: Urinary Tract Infection (UTI) AHRQ

UTI Toolkit

Toolkit for Reducing CAUTI in Hospitals AHRQ

Appendix K. Infographic Poster on CAUTI Prevention (ahrq.gov)

UTI Clinical Pearls

Single-Dose Aminoglycoside for Cystitis: An Oldie but Goodie – KY Antimicrobial Stewardship Innovation Consortium

Staphylococcus aureus in a urine culture – KY Antimicrobial Stewardship Innovation Consortium

Aminopenicillins for Enterococcal Cystitis: Teaching an Old Dog New Tricks – KY Antimicrobial Stewardship Innovation Consortium

Skin and Soft Tissue Infection

Cellulitis: A Review (JAMA)

Cellulitis: A Review (NIH)

Cellulitis: Information for Clinicians (CDC)

IDSA Skin & Soft Tissue guidelines 2014

Skin and Soft Tissue Infections: Treatment Guidance Jasmine R Marcelin MD, Trevor Van Schooneveld MD, Scott Bergman PharmD Reviewed by: Mark E Rupp MD, M. Salman Ashraf MBBS

AAFP patient education materials

UCSF Medical Center Guideline for the Management of Suspected Skin and Soft Tissue Infections in Adults Original Author(s): Jennifer S. Mulliken, MD and Sarah M. Doernberg, MD, MAS

SHC Clinical Guideline: Outpatient Management of Skin and Soft Tissue Infections

Prophylaxis/SSI

Strategies to prevent surgical site infections in acute-care hospitals: 2022 Update with essential practices. 

Additional guidelines (all adapted from consensus guidelines):

ASHP Clinical Practice Guidelines for Prophylaxis in Surgery.

Stanford Health Care- Surgical Prophylaxis Guidelines

University of Michigan- Surgical Prophylaxis Guidelines

University of California San Francisco- Surgical Prophylaxis Guidelines

ICHE Compendium 2022- Updated Surgical Site Infection Prevention Compendium

IV to PO Conversion

Article – Intravenous-to-Oral Switch Therapy: Overview, Antibiotics, Antidepressants (medscape.com)

Article – (2023) – Switching patients from IV to oral antimicrobials – The Pharmaceutical Journal (pharmaceutical-journal.com) (from the UK)

Guidelines

Galway Antimicrobial Prescribing Policy / Guidelines (GAPP) – Galway: GAPP (megsupporttools.com)

 (2018) Intravenous to Oral Conversion for Antimicrobials (northernhealth.ca)

SHC-IV-to-PO-Interchange-Protocol.pdf (stanford.edu)

A Resource To Help With Changing From IV To PO Antibiotics (idstewardship.com)

Public Health Ontario: https://www.publichealthontario.ca/-/media/documents/A/2016/asp-iv-oral-conversion.pdf

Community Acquired Pneumonia- Updated Recommendations ATS and IDSA 2020

ATS/IDSA Guidelines for Diagnosis and Treatment of Adults with Community Acquired Pneumonia 2019

C. difficile

Clinical-Pearl-CDI-Risk-2.8.23.pdf (kymdro.org)

CDI Prevention Strategies- https://www.cdc.gov/cdiff/clinicians/cdi-prevention-strategies.html

MN Department of Health C difficile guidelines  https://www.health.state.mn.us/diseases/cdiff/hcp/guidelines.html

UC Davis Guidelines 2021  https://health.ucdavis.edu/antibiotic-stewardship/pdfs/cdi_tx_ucd.pdf

University of Nebraska  2021 https://www.unmc.edu/intmed/_documents/id/asp/clinicpath-cdi_final.pdf

UNC Medical Center 2022  https://www.med.unc.edu/pediatrics/cccp/wp-content/uploads/sites/1156/gravity_forms/1-c06e424ddddee8826f29e1bc5926a251/2022/11/CASP-UNCMC-CDI-Guideline_FINAL.pdf

AHRQ  Best Practices in the Diagnosis and Treatment of C difficile 2019  

Management of C difficile in adults: review and comparison of IDSA/SHEA, ESCMID and ASID guidelines

IDSA C difficile clinical practice guidelines in adults: 2021 Update by SHEA/IDSA

Collection: Antibiotic Stewardship Success Stories

Compiled by IPRO NQIIC

The following multimedia collection focuses on highlighting Antibiotic Stewardship success stories. Materials include PDFs, videos, and podcasts. This collection will be updated with additional resources as they become available.

  1. Astera Health (MN) Antibiotic Stewardship Success – Astera Health.
  2. Rockcastle Regional Hospital and Respiratory Care Center Antibiotic De-escalation Program – Rockcastle Regional Hospital

April 18, 2023 LAN Event – Using TAP Strategy for HAI Reduction: CAUTI, CLABSI, C. diff, MRSA

Prepared by IPRO HQIC

Join us for a webinar featuring subject matter experts from the Centers for Disease Control and Prevention (CDC) to learn about a comprehensive strategy to reduce hospital acquired infections (HAI). The Targeted Assessment for Prevention (TAP) Strategy is a CDC-developed framework for quality improvement that uses data to drive interventions that will prevent healthcare-associated infections. The TAP strategy targets healthcare facilities and specific units within facilities that have a disproportionate burden of HAIs so that prevention efforts can be prioritized and implemented where they will have the greatest impact. Our speakers will discuss the latest updates in the strategy and tools, including adaptation for smaller facilities.

Patient Stories Collection: Infectious Diseases

Compiled by IPRO HQIC

The following are websites where you can find patient stories related to infectious diseases:

1. Infectious Diseases Society of America (IDSA). IDSA Home [Internet]. Patient Stories: The Faces of Antimicrobial Resistance; [cited 2023 Aug 8]. Available from: https://www.idsociety.org/public-health/patient-stories/patient-stories/.

2. Pew Charitable Trusts. The Pew Charitable Trusts | The Pew Charitable Trusts [Internet]. True Stories of Antibiotic Resistance; 2017 Nov 13 [cited 2023 Aug 8]. Available from: https://www.pewtrusts.org/en/research-and-analysis/articles/2017/11/true-stories-of-antibiotic-resistance-3-personal-perspectives.

3. National Foundation for Infectious Diseases (NFID). NFID [Internet]. Real Stories, Real People – NFID; [cited 2023 Aug 8]. Available from: https://www.nfid.org/resources/real-stories-real-people/.

4. Sepsis Alliance [Internet]. Faces of Sepsis; [cited 2023 Aug 11]. Available from: https://www.sepsis.org/education/patients-family/faces-of-sepsis/.

5. Summa Health | Nonprofit Healthcare System in Akron, Ohio [Internet]. Infectious Disease Patient Stories | Summa Health; [cited 2023 Aug 11]. Available from: https://www.summahealth.org/specializedservices/infectious-diseases/patient-stories

6. Cleveland Clinic [Internet]. Infectious Disease Patient Stories | Cleveland Clinic; [cited 2023 Aug 11]. Available from: https://my.clevelandclinic.org/patient-stories/infectious-disease

7. St. Jude Children’s Research Hospital [Internet]. Infectious Diseases Treatment Patient Stories; [cited 2023 Aug 11]. Available from: https://www.stjude.org/treatment/disease/infectious-diseases/patient-stories.html

8. Patient Stories and Patient Safety [Internet] CDC. Published September 13, 2023. [Cited September 18, 2023]. Available from: https://blogs.cdc.gov/safehealthcare/category/patients/

9. COVID-19 Patient Stories. [Internet] www.hopkinsmedicine.org. [Cited September 18, 2023]. Available from: https://www.hopkinsmedicine.org/coronavirus/patient-stories

10. HQIC Antibiotic Stewardship Workgroup: Clostridioides difficile Module. [Internet] IPRO NQIIC. [Cited September 18, 2023]. Available from: https://qi.ipro.org/2022/04/21/hqic-antibiotic-stewardship-workgroup-clostridioides-difficile-module/

‌

‌

Joint HQIC Antibiotic Stewardship: Quick Wins for Improving Duration of Therapy – November 8, 2022

Prepared by IPRO HQIC

Antibiotic Stewardship (AS) remains a national priority aimed at optimizing antibiotic use to effectively treat infections, protect patients from harms caused by unnecessary use and combat antibiotic resistance. This event features national antibiotic use and duration of therapy (DOT) trending data, strategies to address AS challenges, examples of best practice to improve antibiotic discharge prescribing, and a hospital’s success with engaging leaders, providers and front-line staff in a hospital-wide initiative to improve DOT and outcomes.

HQIC Antibiotic Stewardship Workgroup- Clostridioides difficile Module

Prepared by IPRO QIN/QIO

Video interview with a nurse describing her own C.  difficile survival story. The story includes a first-person accounting of her yearlong hospitalization, the impact of antibiotic therapy, prevention of C. difficile and the long-term effects of this devastating antibiotic adverse event.

HQIC Antibiotic Stewardship Workgroup: Penicillin Allergy Module

Developed by the Network of Quality Improvement and Innovation Contractors for the Centers of Medicare and Medicaid Services Quality Improvement and Innovation Group – QIN/QIO HQIC

This resource contains two video conversations on how to develop and maintain a successful penicillin allergy program, and how to initiate and sustain an antibiotic allergy clarification program. Additional resources include CDC fact sheet, allergy poster, and Evaluation and Diagnosis of Penicillin Allergy for Healthcare Professionals documentation.

HQIC Webinar, November 4, 2021: Antibiotic Stewardship During A COVID Pandemic

Prepared by IPRO HQIC

This resources includes a recording and presentation slides from a November Webinar on Antibiotic Stewardship During the Covid Pandemic.

Antibiotic Stewardship (AS) is a national priority aimed at optimizing the use of antibiotics to effectively treat infections, protect patients from harms caused by unnecessary antibiotic use, and combat antibiotic resistance. Hospital AS programs and teams have been challenged during the COVID pandemic to manage both viral and bacterial infections in patients for extended lengths of stay.